DRESS syndrome secondary to iodinated supplement
DOI:
https://doi.org/10.32818/reccmi.a6n3a7Keywords:
Iodine, DRESS syndrome, eosinophilia.Abstract
DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) is a life-threatening drug reaction that includes an extensive skin rash, hematologic abnormalities (eosinophilia), lymphadenopathy, and organ involvement such as liver, kidney, and lungs. We report the case of a 37-year-old nursing woman who suffered a DRESS syndrome secondary to the intake of iodine supplements. Given the potential severity of that syndrome, and the facility to obtain nutritional supplements without a prescription, we believe it is interesting to share this case to help the physicians suspect this possibility and guide in the diagnosis and management.
Downloads
Metrics
References
Ocampo-Garza J, Ocampo-Garza SS, Martínez-Villarreal JD, Barbosa-Moreno LE, Guerrero-González GA, Ocampo-Candiani J. Reacción por drogas con eosinofilia y síntomas sistémicos (síndrome de DRESS): Estudio retrospectivo de nueve casos. Rev Med Chil. 2015; 143(5): 577-83. doi: https://doi.org/10.4067/S0034-98872015000500004.
Lee HY. Drug reaction with eosinophilia and systemic symptoms (DRESS). In: UpToDate, Mockenhaupt M, (Ed). Corona R, (Ed). UpToDate, Waltham, MA, 2020. Disponible en: http://www.uptodate.com.
Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013; 169: 1071-80. doi: https://doi.org/10.1111/bjd.12501.
Cho YT, Yang CW, Chu CY. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An interplay among drugs, viruses, and immune system. Int J Mol Sci. 2017; 18(6): 1243. doi: https://doi.org/10.3390/ijms18061243.
Kohn V, Carrizo D, Arato G, Arroyo F. Síndrome de DRESS en una paciente con fibrosis quística: reporte de un caso pediátrico. Arch Argent Pediatr 2021;119(3): e234-e238. doi: https://doi.org/10.5546/aap.2021.e234.
Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000; 43(4): 691-7. doi: https://doi.org/10.1067/mjd.2000.107247.
Sowa J, Tsuruta D, Nakanishi T, Kobayashi H, Ishii M. Generalized dermatitis with eosinophilia resulting from allergic contact dermatitis due to povidone iodine. Contact Dermatitis. 2006; 54(3): 174-6. doi: https://doi.org/10.1111/j.0105-1873.2005.0739g.x.
Macías EM, Muñoz-Bellido FJ, Velasco A, Moreno E, Dávila I. DRESS syndrome involving 2 unrelated substances: imipenem and iodinated contrast media. J Investig Allergol Clin Immunol. 2013;23(1):56-7.
Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med 2011; 124(7): 588-97. doi: https://doi.org/10.1016/j.amjmed.2011.01.017.
Taweesedt PT, Nordstrom CW, Stoeckel J, Dumic I. Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review. Biomed Res Int. 2019 Sep 24; 2019: 7863815. doi: https://doi.org/10.1155/2019/7863815.
Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965; 58(5): 295-300.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Blanca Alonso-Martínez, Juan Cantón-de-Seoane, Nagore Lois-Martínez, Pablo del-Valle-Loarte
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
